The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials - Université Claude Bernard Lyon 1
Journal Articles JAMA oncology Year : 2016

The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials

Domains

Life Sciences [q-bio]

Lauriane Pillet  : Connect in order to contact the contributor

https://univ-lyon1.hal.science/hal-02053619

Submitted on : Friday, March 1, 2019-2:33:24 PM

Last modification on : Sunday, May 19, 2024-3:09:56 AM

Consult the full text

Dates and versions

hal-02053619 , version 1 (01-03-2019)

Identifiers

Cite

Julien Péron, Pascal Roy, B. Ozenne, L. Roche, M. Buyse. The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials. JAMA oncology, 2016, 2, pp.901-905. ⟨10.1001/jamaoncol.2015.6359⟩. ⟨hal-02053619⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

HCL CNRS UNIV-LYON1 BIOENVIS LBBE UDL
24 View
0 Download

Altmetric

Share

More